HEADER IMMUNOGLOBULIN 29-SEP-81 3FAB OBSLTE 31-JAN-94 3FAB 7FAB TITLE PRELIMINARY REFINEMENT AND STRUCTURAL ANALYSIS OF THE FAB TITLE 2 FRAGMENT FROM HUMAN IMMUNOGLOBULIN NEW AT 2.0 ANGSTROMS TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: L; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE:; COMPND 7 CHAIN: H; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2 KEYWDS IMMUNOGLOBULIN EXPDTA X-RAY DIFFRACTION AUTHOR R.J.POLJAK,L.M.AMZEL,B.L.CHEN,R.P.PHIZACKERLEY,F.SAUL REVDAT 6 31-JAN-94 3FAB 3 OBSLTE REVDAT 5 17-FEB-84 3FAB 1 REMARK REVDAT 4 30-SEP-83 3FAB 1 REVDAT REVDAT 3 25-OCT-82 3FAB 3 REMARK FTNOTE ATOM REVDAT 2 02-MAR-82 3FAB 1 REMARK REVDAT 1 08-DEC-81 3FAB 0 SPRSDE 08-DEC-81 3FAB 2FAB JRNL AUTH F.A.SAUL,L.M.AMZEL,R.J.POLJAK JRNL TITL PRELIMINARY REFINEMENT AND STRUCTURAL ANALYSIS OF JRNL TITL 2 THE FAB FRAGMENT FROM HUMAN IMMUNOGLOBULIN NEW AT JRNL TITL 3 2.0 ANGSTROMS RESOLUTION JRNL REF J.BIOL.CHEM. V. 253 585 1978 JRNL REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.J.POLJAK,L.M.AMZEL,B.L.CHEN,R.P.PHIZACKERLEY, REMARK 1 AUTH 2 F.SAUL REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF REMARK 1 TITL 2 A HUMAN MYELOMA IMMUNOGLOBULIN REMARK 1 EDIT E.HABER, R.M.KRAUSE REMARK 1 REF ANTIBODIES IN HUMAN 111 1977 REMARK 1 REF 2 DIAGNOSIS AND THERAPY REMARK 1 PUBL RAVEN PRESS,NEW YORK REMARK 1 REFN ISBN 0-89004-089-3 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.J.POLJAK,L.M.AMZEL,B.L.CHEN,R.P.PHIZACKERLEY, REMARK 1 AUTH 2 F.SAUL REMARK 1 TITL THE THREE DIMENSIONAL STRUCTURE OF THE FABFRAGMENT REMARK 1 TITL 2 OF A HUMAN MYELOMA IMMUNOGLOBULIN AT 2.0-ANGSTROMS REMARK 1 TITL 3 RESOLUTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 71 3440 1974 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REFERENCE 3 REMARK 1 AUTH B.L.CHEN,R.J.POLJAK REMARK 1 TITL AMINO ACID SEQUENCE OF THE (LAMBDA) LIGHT CHAIN OF REMARK 1 TITL 2 A HUMAN MYELOMA IMMUNOGLOBULIN (IGG NEW) REMARK 1 REF BIOCHEMISTRY V. 13 1295 1974 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.J.POLJAK,L.M.AMZEL,H.P.AVEY,B.L.CHEN, REMARK 1 AUTH 2 R.P.PHIZACKERLEY,F.SAUL REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF THE FABFRAGMENT OF REMARK 1 TITL 2 A HUMAN IMMUNOGLOBULIN AT 2.8-ANGSTROMS RESOLUTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 70 3305 1973 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REFERENCE 5 REMARK 1 EDIT M.O.DAYHOFF REMARK 1 REF ATLAS OF PROTEIN SEQUENCE V. 5 255 1972 REMARK 1 REF 2 AND STRUCTURE (DATA SECTION) REMARK 1 PUBL NATIONAL BIOMEDICAL RESEARCH FOUNDATION, SILVER REMARK 1 PUBL 2 SPRING,MD. REMARK 1 REFN ISBN 0-912466-02-2 REMARK 2 REMARK 2 RESOLUTION. NULL ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3189 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3FAB COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 3FAB CORRECTION. CHANGE CODEN FOR REFERENCE 2. 02-MAR-82. REMARK 5 3FAB REMARK 6 REMARK 6 3FAB CORRECTION. INSERT CAUTIONARY NOTE AND ADD FTNOTE 1 TO REMARK 6 3FAB RESIDUE ILE H 100. 25-OCT-82. 3FAB REMARK 7 REMARK 7 3FAB CAUTION(WARNING). THIS COORDINATE SET SHOULD BE REMARK 7 REGARDED 3FAB AS A PRELIMINARY DEPOSITION FROM THE AUTHORS. REMARK 7 EXTENSIVE 3FAB CHECKING FOR ERRORS AND FOR POSSIBLE REMARK 7 ADJUSTMENTS ARE STILL 3FAB IN PROGRESS AND A NEW AND FINAL REMARK 7 SET WILL BE DEPOSITED WHEN 3FAB THIS PROCESS IS COMPLETED. REMARK 7 3FAB REMARK 8 REMARK 8 3FAB CORRECTION. INSERT REVDAT RECORDS. 30-SEP-83. 3FAB REMARK 9 REMARK 9 3FAB CORRECTION. CORRECT JOURNAL NAME FOR REFERENCE 4. 3FAB REMARK 9 17-FEB-84. 3FAB REMARK 10 REMARK 10 3FAB CORRECTION. THIS ENTRY IS OBSOLETE. 31-JAN-94. 3FAB REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 1/2+X,1/2+Y,Z REMARK 290 4555 1/2-X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 55.71500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.34000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 55.71500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.34000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PCA L 1 CG CD OE REMARK 470 PCA H 1 CG CD OE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 OE1 GLN H 6 O GLN H 109 1.57 REMARK 500 O ILE H 100 N GLY H 102 1.68 REMARK 500 O GLU L 125 N GLN L 128 1.75 REMARK 500 O HIS L 199 N GLY L 201 1.80 REMARK 500 OD2 ASP L 84 NH1 ARG H 43 1.85 REMARK 500 O GLU L 125 N LEU L 127 1.86 REMARK 500 OH TYR L 179 OG SER H 183 1.89 REMARK 500 O SER H 176 N GLY H 178 1.90 REMARK 500 NZ LYS L 131 NZ LYS H 147 1.92 REMARK 500 O GLY H 102 N ILE H 104 2.04 REMARK 500 O SER H 192 N THR H 195 2.06 REMARK 500 O ASP L 91 N SER L 93 2.09 REMARK 500 O LYS H 205 N SER H 207 2.10 REMARK 500 O LYS H 205 N ASN H 208 2.11 REMARK 500 O SER H 192 OG1 THR H 195 2.12 REMARK 500 CD GLN H 6 O GLN H 109 2.16 REMARK 500 O LEU H 193 N THR H 195 2.17 REMARK 500 OD2 ASP L 84 NH2 ARG H 43 2.18 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASN L 50 CB ARG H 43 4455 2.16 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO H 153 CD PRO H 153 N 0.182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU L 134 CA - CB - CG ANGL. DEV. = 26.0 DEGREES REMARK 500 LYS L 168 CA - CB - CG ANGL. DEV. = 40.2 DEGREES REMARK 500 ARG H 13 CB - CG - CD ANGL. DEV. = 28.4 DEGREES REMARK 500 ARG H 66 CD - NE - CZ ANGL. DEV. = 27.1 DEGREES REMARK 500 GLU H 152 O - C - N ANGL. DEV. = 31.0 DEGREES REMARK 500 PRO H 153 C - N - CA ANGL. DEV. = 44.1 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG L 92 -61.57 53.19 REMARK 500 ASP L 140 128.36 69.73 REMARK 500 PHE L 141 77.27 149.22 REMARK 500 ALA L 145 115.42 106.46 REMARK 500 ASP L 153 -67.72 64.40 REMARK 500 ASN L 171 -53.17 64.48 REMARK 500 GLN L 186 -87.48 77.63 REMARK 500 TRP L 187 -52.22 106.51 REMARK 500 GLU L 200 54.18 -23.14 REMARK 500 THR L 211 123.60 25.05 REMARK 500 CYS L 213 -50.53 117.84 REMARK 500 SER H 15 -32.34 104.05 REMARK 500 ARG H 43 147.89 70.94 REMARK 500 SER H 65 -61.35 140.79 REMARK 500 ASN H 72 -139.35 -0.96 REMARK 500 SER H 74 -37.75 117.90 REMARK 500 SER H 84 -105.16 77.15 REMARK 500 VAL H 85 134.98 73.39 REMARK 500 ILE H 100 -165.51 -4.90 REMARK 500 CYS H 103 -50.43 36.92 REMARK 500 ASP H 105 76.31 145.68 REMARK 500 SER H 134 -93.80 104.05 REMARK 500 THR H 135 177.91 109.73 REMARK 500 SER H 136 -40.97 99.62 REMARK 500 SER H 176 -138.39 9.45 REMARK 500 SER H 177 57.80 -0.25 REMARK 500 LEU H 179 144.39 94.54 REMARK 500 SER H 190 -57.60 101.97 REMARK 500 SER H 219 -115.29 78.21 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU H 152 PRO H 153 84.45 SEQRES 1 L 208 PCA SER VAL LEU THR GLN PRO PRO SER VAL SER GLY ALA SEQRES 2 L 208 PRO GLY GLN ARG VAL THR ILE SER CYS THR GLY SER SER SEQRES 3 L 208 SER ASN ILE GLY ALA GLY ASN HIS VAL LYS TRP TYR GLN SEQRES 4 L 208 GLN LEU PRO GLY THR ALA PRO LYS LEU LEU ILE PHE HIS SEQRES 5 L 208 ASN ASN ALA ARG PHE SER VAL SER LYS SER GLY SER SER SEQRES 6 L 208 ALA THR LEU ALA ILE THR GLY LEU GLN ALA GLU ASP GLU SEQRES 7 L 208 ALA ASP TYR TYR CYS GLN SER TYR ASP ARG SER LEU ARG SEQRES 8 L 208 VAL PHE GLY GLY GLY THR LYS LEU THR VAL LEU ARG GLN SEQRES 9 L 208 PRO LYS ALA ALA PRO SER VAL THR LEU PHE PRO PRO SER SEQRES 10 L 208 SER GLU GLU LEU GLN ALA ASN LYS ALA THR LEU VAL CYS SEQRES 11 L 208 LEU ILE SER ASP PHE TYR PRO GLY ALA VAL THR VAL ALA SEQRES 12 L 208 TRP LYS ALA ASP SER SER PRO VAL LYS ALA GLY VAL GLU SEQRES 13 L 208 THR THR THR PRO SER LYS GLN SER ASN ASN LYS TYR ALA SEQRES 14 L 208 ALA SER SER TYR LEU SER LEU THR PRO GLU GLN TRP LYS SEQRES 15 L 208 SER HIS LYS SER TYR SER CYS GLN VAL THR HIS GLU GLY SEQRES 16 L 208 SER THR VAL GLU LYS THR VAL ALA PRO THR GLU CYS SER SEQRES 1 H 220 PCA VAL GLN LEU GLU GLN SER GLY PRO GLY LEU VAL ARG SEQRES 2 H 220 PRO SER GLN THR LEU SER LEU THR CYS THR VAL SER GLY SEQRES 3 H 220 THR SER PHE ASP ASP TYR TYR SER THR TRP VAL ARG GLN SEQRES 4 H 220 PRO PRO GLY ARG GLY LEU GLU TRP ILE GLY TYR VAL PHE SEQRES 5 H 220 TYR HIS GLY THR SER ASP THR ASP THR PRO LEU ARG SER SEQRES 6 H 220 ARG VAL THR MET LEU VAL ASN THR SER LYS ASN GLN PHE SEQRES 7 H 220 SER LEU ARG LEU SER SER VAL THR ALA ALA ASP THR ALA SEQRES 8 H 220 VAL TYR TYR CYS ALA ARG ASN LEU ILE ALA GLY CYS ILE SEQRES 9 H 220 ASP VAL TRP GLY GLN GLY SER LEU VAL THR VAL SER SER SEQRES 10 H 220 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 11 H 220 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 12 H 220 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 13 H 220 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 14 H 220 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 15 H 220 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 16 H 220 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 17 H 220 THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS MODRES 3FAB PCA L 1 GLU PYROGLUTAMIC ACID MODRES 3FAB PCA H 1 GLU PYROGLUTAMIC ACID FTNOTE 1 THE CONFORMATION OF THE PEPTIDE GROUP OF RESIDUE ILE H 100 FTNOTE 1 HAS BEEN FOUND TO BE IN NEED OF SOME MINOR ADJUSTMENTS AND FTNOTE 1 WILL BE CORRECTED IN A SUBSEQUENT DEPOSITION. HET PCA L 1 5 HET PCA H 1 5 HETNAM PCA PYROGLUTAMIC ACID FORMUL 1 PCA 2(C5 H7 N O3) HELIX 1 H1 SER L 26 GLY L 27C 3 5 HELIX 2 H2 GLN L 78 GLU L 82 1DISTORTED PI OR ALPHA HELIX 5 HELIX 3 H3 THR H 86 THR H 90 1DISTORTED PI OR ALPHA HELIX 5 HELIX 4 H4 SER H 190 THR H 195 1ALPHA HELIX 6 SHEET 1 VL1 4 PCA L 1 THR L 5 0 SHEET 2 VL1 4 GLN L 16 SER L 25 -1 SHEET 3 VL1 4 SER L 68 THR L 75 -1 SHEET 4 VL1 4 ARG L 53 SER L 66 -1 SHEET 1 VL2 5 PRO L 7 GLY L 12 0 SHEET 2 VL2 5 LEU L 94 LEU L 108 1 SHEET 3 VL2 5 ALA L 83 ASP L 91 -1 SHEET 4 VL2 5 HIS L 31 LEU L 38 -1 SHEET 5 VL2 5 THR L 41 LEU L 46 -1 SHEET 1 CL1 4 SER L 116 PHE L 120 0 SHEET 2 CL1 4 ALA L 132 ASP L 140 -1 SHEET 3 CL1 4 LYS L 173 LEU L 182 -1 SHEET 4 CL1 4 GLY L 160 GLN L 169 -1 SHEET 1 CL2 3 THR L 147 LYS L 151 0 SHEET 2 CL2 3 TYR L 193 HIS L 199 -1 SHEET 3 CL2 3 SER L 202 VAL L 208 -1 SHEET 1 VH1 5 VAL H 67 LYS H 75 0 SHEET 2 VH1 5 ASN H 76 VAL H 85 -1 SHEET 3 VH1 5 SER H 15 SER H 25 -1 SHEET 4 VH1 5 PCA H 1 ARG H 13 -1 SHEET 5 VH1 5 VAL H 115 ALA H 118 1 SHEET 1 VH2 5 HIS H 54 ASP H 58 0 SHEET 2 VH2 5 ARG H 43 TYR H 53 -1 SHEET 3 VH2 5 TYR H 33 PRO H 41 -1 SHEET 4 VH2 5 VAL H 92 ALA H 101 -1 SHEET 5 VH2 5 CYS H 103 THR H 114 -1 SHEET 1 CH1 4 THR H 120 ALA H 129 0 SHEET 2 CH1 4 ALA H 141 PHE H 150 -1 SHEET 3 CH1 4 GLY H 178 VAL H 188 -1 SHEET 4 CH1 4 GLY H 166 SER H 176 -1 SHEET 1 CH2 3 THR H 155 LEU H 163 0 SHEET 2 CH2 3 TYR H 198 LYS H 205 -1 SHEET 3 CH2 3 ASN H 208 GLU H 216 -1 SSBOND 1 CYS L 22 CYS L 87 SSBOND 2 CYS L 136 CYS L 195 SSBOND 3 CYS L 213 CYS H 220 SSBOND 4 CYS H 22 CYS H 95 SSBOND 5 CYS H 144 CYS H 200 CISPEP 1 PHE H 150 PRO H 151 0 -1.14 CRYST1 111.430 56.680 90.300 90.00 116.46 90.00 C 1 2 1 4 ORIGX1 0.008974 0.000000 0.004467 0.00000 ORIGX2 0.000000 0.017643 0.000000 0.00000 ORIGX3 0.000000 0.000000 0.012370 0.00000 SCALE1 0.008974 0.000000 0.004467 0.00000 SCALE2 0.000000 0.017643 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012370 0.00000 HETATM 1 N PCA L 1 -41.330 11.030 3.090 1.00 0.00 N HETATM 2 CA PCA L 1 -40.920 12.400 3.310 1.00 0.00 C HETATM 3 CB PCA L 1 -39.460 12.650 3.020 1.00 0.00 C HETATM 4 C PCA L 1 -41.860 13.320 2.510 1.00 0.00 C HETATM 5 O PCA L 1 -41.660 13.820 1.420 1.00 0.00 O